Condition: Osteoarthritis · Sponsor: Next Biomedical Co., Ltd.
Among knee degenerative osteoarthritis patients aged 50 or older, it will prove the therapeutic effect and safety of Nexsphere-F embolization for patients who need additional treatment because pain is not controlled even if conventional treatments are taken.
This description comes directly from the study's public registry record.
Hyuckmin Kwon · +82-32-454-4800 · next@nextbiomedical.co.kr
Sungmo Moon · +82-32-454-4800 · next@nextbiomedical.co.kr
Always discuss trial participation with your own doctor first.
| Severance Hospital | Seoul, Seodaemun-gu, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05917028